| NCT ID | NCT06492746 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Becton, Dickinson and Company |
| Condition | Blood Pressure |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-06-03 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2024-06-03 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A single-center, prospective, observational pilot of the Cerebral Adaptive Index for assessing personalized blood pressure targets
Eligibility Criteria
Inclusion Criteria: 1. Signed informed consent 2. Age ≥ 45 years 3. Planned cardiac surgery with Cardiopulmonary Bypass (CPB) 4. Planned monitoring with ForeSight sensor and HemoSphere monitor 5. Planned arterial catheterization for blood pressure monitoring 6. High risk for cerebral vascular disease, defined as: a history of hypertension, pulse pressure \> 60 mmHg, diabetes, stroke, transient ischemic attack, carotid bruit, tobacco smoking, or peripheral vascular disease Exclusion Criteria: 1. Non-English speaking 2. Confirmed to be pregnant 3. Surgery for congenital heart defect 4. Non-availability of HemoSphere with laptop CAI interface
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06492746 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, studying Blood Pressure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06492746 currently recruiting?
Yes, NCT06492746 is actively recruiting participants. Contact the research team at cc_clinical_affairs@edwards.com for enrollment information.
Where is the NCT06492746 trial being conducted?
This trial is being conducted at Evanston, United States.
Who is sponsoring the NCT06492746 clinical trial?
NCT06492746 is sponsored by Becton, Dickinson and Company. The trial plans to enroll 120 participants.